A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension
Palmer, A. J. et al.
Current medical research and opinion. VOL 22; NUMB 11, ; 2006, 2095-2100 -- LIBRA PHARM LTD (pages 2095-2100) -- 2006
Online access
